Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 3, 2009, Pages 578-585

  Akpinar, Erhan ^a   Turkbey, Baris ^a   Karcaaltincaba, Musturay ^a   Balli, Omur ^a   Akkapulu, Nezih ^a   Balas, Sener ^a   Tirnaksiz, Bulent ^a   Akata, Deniz ^a   Akhan, Okan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute cholecystitis; Contrast enhanced MR cholangiography; Gd BOPTA

Indexed keywords

GADOBENATE DIMEGLUMINE;

ACUTE CHOLECYSTITIS; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLELITHIASIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYSTIC DUCT; FEMALE; GALLBLADDER; HISTOPATHOLOGY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; AGED; CHILD; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLECYSTITIS, ACUTE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; GALLBLADDER; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MALE; MEGLUMINE; MIDDLE AGED; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 69449103071     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21887     Document Type: Article

References (28)

1. Lim JH. Oriental cholangiohepatitis: pathologic, clinical, and radiologic features. AJR Am J Roentgenol 1991;157:1-8.
2. Ralls PW, Colletti PM, Lapin SA, et al. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology 1985;155:767-771.
3. Reinhold C, Bret PM. Current status of MR cholangiopancreatography. AJR Am J Roentgenol 1996;166:1285-1295.
4. Chan YL, Chan AC, Lam WW, et al. Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography. Radiology 1996;200:85-89. (Pubitemid 26197343)
5. Becker CD, Grossholz M, Becker M, Mentha G, de Peyer R, Terrier F. Choledocholithiasis and bile duct stenosis: accuracy of MR cholangiopancreatography. Radiology 1997;205:523-530. (Pubitemid 27467336)
6. Kim KW, Park MS, Yu JS, et al. Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study. Radiology 2003;227:580-584.
7. Papanikolaou N, Prassopoulos P, Eracleous E, Maris T, Gogas C, Gourtsoyiannis N. Contrast-enhanced magnetic resonance cholangiography versus heavily T2-weighted magnetic resonance cholangiography. Invest Radiol 2001;36:682-686. (Pubitemid 33021097)
8. Lee VS, Rofsky NM, Morgan GR, et al. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR Am J Roentgenol 2001;176:906-908.
9. Kapoor V, Peterson MS, Baron RL, Patel S, Eghtesad B, Fung JJ. Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol 2002; 179:1281-1286. (Pubitemid 35204387)
10. Lim JS, Kim MJ, Jung YY, Kim KW. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. Korean J Radiol 2005;6:229-234.
11. Lim JS, Kim MJ, Kim JH, et al. Preoperative MRI of potential livingdonor- related liver transplantation using a single dose of gadobenate dimeglumine. AJR Am J Roentgenol 2005;185:424-431.
12. Ergen FB, Akata D, Sarikaya B, et al. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings. J Comput Assist Tomogr 2008;32:54-60. (Pubitemid 351317318)
13. Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB. Contrastenhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 2007;48:362-368. (Pubitemid 46633865)
14. Park MS, Kim BC, Kim T, Kim J, Kim KW. Double common bile duct: curved-planar reformatted computed tomography (CT) and gadobenate dimeglumine-enhanced MR cholangiography. J Magn Reson Imaging 2008;27:209-211.
15. Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A. Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 1998;5(Suppl 1):S86-S9; discussion S93-S94.
16. de Haën C, Lorusso V, Luzzani F, Tirone P. Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat. Acad Radiol 1995;2:232-238.
17. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331. (Pubitemid 33041104)
18. Lin EC, Kuni CC. Radionuclide imaging of hepatic and biliary disease. Semin Liver Dis 2001;21:179-194.
19. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
20. Runge VM. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr 1998;22:643-650.
21. Regan F, Schaefer DC, Smith DP, Petronis JD, Bohlman ME, Magnuson TH. The diagnostic utility of HASTE MRI in the evaluation of acute cholecystitis. Half-Fourier acquisition single-shot turbo SE. J Comput Assist Tomogr 1998;22:638-642.
22. Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 2001;9:745-766. (Pubitemid 33048813)
23. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics 2006;26:1621-1636.
24. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999;6:282-291. (Pubitemid 32673373)
25. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
26. Schuhmann-Giampieri G, Mahler M, Röll G, Maibauer R, Schmitz S. Pharmacokinetics of the liver-specific contrast agent Gd-EOBDTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37:587-596. (Pubitemid 27443539)
27. Planchamp C, Pastor CM, Balant L, Becker CD, Terrier F, Gex- Fabry M. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA. Invest Radiol 2005;40: 705-714. (Pubitemid 41546837)
28. Caudana R, Morana G, Pirovano GP, et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra- acetate (BOPTA)-preliminary results of phase II clinical application. Radiology 1996;199:513-520. (Pubitemid 26124278)